{"id":774829,"date":"2023-08-02T22:52:18","date_gmt":"2023-08-03T02:52:18","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/ventyx-biosciences-to-participate-in-the-canaccord-genuity-43rd-annual-growth-conference\/"},"modified":"2023-08-02T22:52:18","modified_gmt":"2023-08-03T02:52:18","slug":"ventyx-biosciences-to-participate-in-the-canaccord-genuity-43rd-annual-growth-conference","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/ventyx-biosciences-to-participate-in-the-canaccord-genuity-43rd-annual-growth-conference\/","title":{"rendered":"Ventyx Biosciences to Participate in the Canaccord Genuity 43rd Annual Growth Conference"},"content":{"rendered":"<div class=\"mw_release\">\n<p align=\"justify\">SAN DIEGO, Aug.  02, 2023  (GLOBE NEWSWIRE) &#8212; Ventyx Biosciences, Inc. (Nasdaq: VTYX) (\u201cVentyx\u201d), a clinical-stage biopharmaceutical company focused on advancing novel oral therapies that address a broad range of inflammatory diseases with significant unmet medical need, today announced that Company executives will participate in a fireside chat at the Canaccord Genuity 43rd Annual Growth Conference being held on August 9, 2023.<\/p>\n<ul type=\"disc\">\n<li>\n          <strong>Event: Canaccord Genuity 43rd Annual Growth Conference<br \/><\/strong>Location: Boston, MA<br \/>Date: Wednesday, August 9, 2023<br \/>Time: 4:30-4:55 PM ET<\/li>\n<\/ul>\n<p align=\"justify\">A webcast of the presentation will be available in the Investors and News section of the Ventyx website at <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=h5p7w2eH9qj7Dy5pwkGPxTQ9yCbHsiup0MsuxqDyOOkLBKB41JcdU3qrVUpVBUIUy9Y831IADdbHTWFu5WfODAuACZ2fa9XcIk1BZzc_WRw=\" rel=\"nofollow noopener\" target=\"_blank\">www.ventyxbio.com<\/a>. A webcast replay will also be available on this website shortly after conclusion of the event for thirty days.<\/p>\n<p align=\"justify\">\n        <strong>About Ventyx Biosciences<\/strong>\n      <\/p>\n<p align=\"justify\">Ventyx is a clinical-stage biopharmaceutical company focused on developing innovative oral medicines for patients living with autoimmune and inflammatory disorders. We believe our ability to efficiently discover and develop differentiated drug candidates will allow us to address important unmet medical need with novel oral therapies that can shift immunology markets from injectable to oral drugs. Our current pipeline includes internally discovered clinical programs targeting TYK2, S1P1R and NLRP3, positioning us to become a leader in the development of oral immunology therapies. Ventyx is headquartered in San Diego, California. For more information about Ventyx, please visit <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=h5p7w2eH9qj7Dy5pwkGPxegCGlZMZBIcyDSfuEs5okzo78zgc8tWMpIGFpfT-sAZXp2gHuDeqcwbv-s177_oQ11Slie9fKKsbGTGrWjhm83fQ4VkW880otQVH4GprE0BHipBeO0ZI-QiwD1SSbjgirMA3vGtIC3WtaInwAEs7n6pPYZeKQxYGGHKk1hr2q-VPZVCdv1uabpWRiymO6mlwjPt_QaHklehB5SjU1Dxwx4=\" rel=\"nofollow noopener\" target=\"_blank\">www.ventyxbio.com<\/a>.<\/p>\n<p align=\"justify\">\n        <strong>Investor Relations Contact<\/strong><br \/>\n        <br \/>Patti Bank<br \/>Managing Director<br \/>ICR Westwicke<br \/>(415) 513-1284<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=fQQDPhbhQVD_b9ZnhIt7dp7jEKXzhfTBG-8VBLXGyGMyX7Cdz3YMP2IXkJnUVh6Fg2dlJbj9KgkqyCeaPXSgHDZKtcvXYYHpwFfa1beBW-yc_ohPB64BecJESc_Lhf7sK5uH1adnEjxqvYLb9k9wJkWExUR_qJBsW9sTT8JOvMcuaxTFaatppRe_MYIKlKQqN_IHxLCUEpXOSL2P3twPZG-ZgymFVYgdG44NIC0H4n8=\" rel=\"nofollow noopener\" target=\"_blank\">IR@ventyxbio.com<\/a><\/p>\n<p>      <img decoding=\"async\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODg4NjIxNiM1NzMxOTA5IzIyMTA3MjU=\" \/><br \/>\n      <br \/>\n      <img decoding=\"async\" src=\"https:\/\/ml.globenewswire.com\/media\/NDFkNDJiNmUtOGYxMi00OTNhLWIwZjUtZTdkMWVmNDI2NmQxLTEyMjIyNzg=\/tiny\/Ventyx-Biosciences-Inc-.png\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>SAN DIEGO, Aug. 02, 2023 (GLOBE NEWSWIRE) &#8212; Ventyx Biosciences, Inc. (Nasdaq: VTYX) (\u201cVentyx\u201d), a clinical-stage biopharmaceutical company focused on advancing novel oral therapies that address a broad range of inflammatory diseases with significant unmet medical need, today announced that Company executives will participate in a fireside chat at the Canaccord Genuity 43rd Annual Growth Conference being held on August 9, 2023. Event: Canaccord Genuity 43rd Annual Growth ConferenceLocation: Boston, MADate: Wednesday, August 9, 2023Time: 4:30-4:55 PM ET A webcast of the presentation will be available in the Investors and News section of the Ventyx website at www.ventyxbio.com. A webcast replay will also be available on this website shortly after conclusion of the event for thirty days. About Ventyx Biosciences &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/ventyx-biosciences-to-participate-in-the-canaccord-genuity-43rd-annual-growth-conference\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Ventyx Biosciences to Participate in the Canaccord Genuity 43rd Annual Growth Conference&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-774829","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.8 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Ventyx Biosciences to Participate in the Canaccord Genuity 43rd Annual Growth Conference - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/ventyx-biosciences-to-participate-in-the-canaccord-genuity-43rd-annual-growth-conference\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Ventyx Biosciences to Participate in the Canaccord Genuity 43rd Annual Growth Conference - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"SAN DIEGO, Aug. 02, 2023 (GLOBE NEWSWIRE) &#8212; Ventyx Biosciences, Inc. (Nasdaq: VTYX) (\u201cVentyx\u201d), a clinical-stage biopharmaceutical company focused on advancing novel oral therapies that address a broad range of inflammatory diseases with significant unmet medical need, today announced that Company executives will participate in a fireside chat at the Canaccord Genuity 43rd Annual Growth Conference being held on August 9, 2023. Event: Canaccord Genuity 43rd Annual Growth ConferenceLocation: Boston, MADate: Wednesday, August 9, 2023Time: 4:30-4:55 PM ET A webcast of the presentation will be available in the Investors and News section of the Ventyx website at www.ventyxbio.com. A webcast replay will also be available on this website shortly after conclusion of the event for thirty days. About Ventyx Biosciences &hellip; Continue reading &quot;Ventyx Biosciences to Participate in the Canaccord Genuity 43rd Annual Growth Conference&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/ventyx-biosciences-to-participate-in-the-canaccord-genuity-43rd-annual-growth-conference\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2023-08-03T02:52:18+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODg4NjIxNiM1NzMxOTA5IzIyMTA3MjU=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/ventyx-biosciences-to-participate-in-the-canaccord-genuity-43rd-annual-growth-conference\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/ventyx-biosciences-to-participate-in-the-canaccord-genuity-43rd-annual-growth-conference\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Ventyx Biosciences to Participate in the Canaccord Genuity 43rd Annual Growth Conference\",\"datePublished\":\"2023-08-03T02:52:18+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/ventyx-biosciences-to-participate-in-the-canaccord-genuity-43rd-annual-growth-conference\\\/\"},\"wordCount\":241,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/ventyx-biosciences-to-participate-in-the-canaccord-genuity-43rd-annual-growth-conference\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODg4NjIxNiM1NzMxOTA5IzIyMTA3MjU=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/ventyx-biosciences-to-participate-in-the-canaccord-genuity-43rd-annual-growth-conference\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/ventyx-biosciences-to-participate-in-the-canaccord-genuity-43rd-annual-growth-conference\\\/\",\"name\":\"Ventyx Biosciences to Participate in the Canaccord Genuity 43rd Annual Growth Conference - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/ventyx-biosciences-to-participate-in-the-canaccord-genuity-43rd-annual-growth-conference\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/ventyx-biosciences-to-participate-in-the-canaccord-genuity-43rd-annual-growth-conference\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODg4NjIxNiM1NzMxOTA5IzIyMTA3MjU=\",\"datePublished\":\"2023-08-03T02:52:18+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/ventyx-biosciences-to-participate-in-the-canaccord-genuity-43rd-annual-growth-conference\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/ventyx-biosciences-to-participate-in-the-canaccord-genuity-43rd-annual-growth-conference\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/ventyx-biosciences-to-participate-in-the-canaccord-genuity-43rd-annual-growth-conference\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODg4NjIxNiM1NzMxOTA5IzIyMTA3MjU=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODg4NjIxNiM1NzMxOTA5IzIyMTA3MjU=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/ventyx-biosciences-to-participate-in-the-canaccord-genuity-43rd-annual-growth-conference\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Ventyx Biosciences to Participate in the Canaccord Genuity 43rd Annual Growth Conference\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Ventyx Biosciences to Participate in the Canaccord Genuity 43rd Annual Growth Conference - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/ventyx-biosciences-to-participate-in-the-canaccord-genuity-43rd-annual-growth-conference\/","og_locale":"en_US","og_type":"article","og_title":"Ventyx Biosciences to Participate in the Canaccord Genuity 43rd Annual Growth Conference - Market Newsdesk","og_description":"SAN DIEGO, Aug. 02, 2023 (GLOBE NEWSWIRE) &#8212; Ventyx Biosciences, Inc. (Nasdaq: VTYX) (\u201cVentyx\u201d), a clinical-stage biopharmaceutical company focused on advancing novel oral therapies that address a broad range of inflammatory diseases with significant unmet medical need, today announced that Company executives will participate in a fireside chat at the Canaccord Genuity 43rd Annual Growth Conference being held on August 9, 2023. Event: Canaccord Genuity 43rd Annual Growth ConferenceLocation: Boston, MADate: Wednesday, August 9, 2023Time: 4:30-4:55 PM ET A webcast of the presentation will be available in the Investors and News section of the Ventyx website at www.ventyxbio.com. A webcast replay will also be available on this website shortly after conclusion of the event for thirty days. About Ventyx Biosciences &hellip; Continue reading \"Ventyx Biosciences to Participate in the Canaccord Genuity 43rd Annual Growth Conference\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/ventyx-biosciences-to-participate-in-the-canaccord-genuity-43rd-annual-growth-conference\/","og_site_name":"Market Newsdesk","article_published_time":"2023-08-03T02:52:18+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODg4NjIxNiM1NzMxOTA5IzIyMTA3MjU=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/ventyx-biosciences-to-participate-in-the-canaccord-genuity-43rd-annual-growth-conference\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/ventyx-biosciences-to-participate-in-the-canaccord-genuity-43rd-annual-growth-conference\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Ventyx Biosciences to Participate in the Canaccord Genuity 43rd Annual Growth Conference","datePublished":"2023-08-03T02:52:18+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/ventyx-biosciences-to-participate-in-the-canaccord-genuity-43rd-annual-growth-conference\/"},"wordCount":241,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/ventyx-biosciences-to-participate-in-the-canaccord-genuity-43rd-annual-growth-conference\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODg4NjIxNiM1NzMxOTA5IzIyMTA3MjU=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/ventyx-biosciences-to-participate-in-the-canaccord-genuity-43rd-annual-growth-conference\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/ventyx-biosciences-to-participate-in-the-canaccord-genuity-43rd-annual-growth-conference\/","name":"Ventyx Biosciences to Participate in the Canaccord Genuity 43rd Annual Growth Conference - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/ventyx-biosciences-to-participate-in-the-canaccord-genuity-43rd-annual-growth-conference\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/ventyx-biosciences-to-participate-in-the-canaccord-genuity-43rd-annual-growth-conference\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODg4NjIxNiM1NzMxOTA5IzIyMTA3MjU=","datePublished":"2023-08-03T02:52:18+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/ventyx-biosciences-to-participate-in-the-canaccord-genuity-43rd-annual-growth-conference\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/ventyx-biosciences-to-participate-in-the-canaccord-genuity-43rd-annual-growth-conference\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/ventyx-biosciences-to-participate-in-the-canaccord-genuity-43rd-annual-growth-conference\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODg4NjIxNiM1NzMxOTA5IzIyMTA3MjU=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODg4NjIxNiM1NzMxOTA5IzIyMTA3MjU="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/ventyx-biosciences-to-participate-in-the-canaccord-genuity-43rd-annual-growth-conference\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Ventyx Biosciences to Participate in the Canaccord Genuity 43rd Annual Growth Conference"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/774829","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=774829"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/774829\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=774829"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=774829"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=774829"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}